Abstract
Inherited prion diseases are caused by PRNP coding mutations and display marked phenotypic heterogeneity within families segregating the same pathogenic mutation. A proline-to-leucine substitution at prion protein (PrP) residue 102 (P102L), classically associated with the Gerstmann-Sträussler-Scheinker (GSS) phenotype, also shows marked clinical and pathological heterogeneity, including patients with a Creutzfeldt-Jakob disease (CJD) phenotype. To date, this heterogeneity has been attributed to temporal and spatial variance in the propagation of distinct protease-resistant (PrPSc) isoforms of mutant PrP. Here, using a monoclonal antibody that recognizes wild-type PrP, but not PrP 102L, we reveal a spectrum of involvement of wild-type PrPSc in P102L individuals. PrPSc isoforms derived from wild-type and mutant PrP are distinct both from each other and from those seen in sporadic and acquired CJD. Such differential propagation of disease-related isoforms of wild-type PrP and PrP 102L provides a molecular mechanism for generation of the multiple clinicopathological phenotypes seen in inherited prion disease. © The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Wadsworth, J. D. F., Joiner, S., Linehan, J. M., Cooper, S., Powell, C., Mallinson, G., … Collinge, J. (2006). Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain, 129(6), 1557–1569. https://doi.org/10.1093/brain/awl076
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.